Dorsey Wright & Associates

Position in ABVX — Abivax S.A.

CIK 1376772 PASADENA, CA

Position in ABVX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$2,218,112

-$393,268 QoQ

Shares Held

16,645

-29.0% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

#144

of 302 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dorsey Wright & Associates holds $27,470,218 across 5 Biotechnology names. ABVX ranks #4 (8.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	391,662	$13,860,918
2	ARWR	Arrowhead Pharmaceuticals, Inc.	97,466	$7,944,453
3	ASND	Ascendis Pharma A/S	8,427	$2,247,649
4	ABVX	Abivax S.A. This page	16,645	$2,218,112
5	DBVT	DBV Technologies S.A.	73,115	$1,199,086

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,218,112	16,645	-29.0%	Shares	Sole	2026-08-06
2026-03-31	$2,611,380	23,452	+41.1%	Shares	Sole	2026-05-06
2025-12-31	$2,241,290	16,620	—	Shares	Sole	2026-02-20
No filing history on record for this holder in this stock.